Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/15075
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDeachapunya C.
dc.contributor.authorThongsaard W.
dc.contributor.authorPoonyachoti S.
dc.date.accessioned2021-04-05T04:32:30Z-
dc.date.available2021-04-05T04:32:30Z-
dc.date.issued2005
dc.identifier.issn3788741
dc.identifier.other2-s2.0-24644524706
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/15075-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-24644524706&doi=10.1016%2fj.jep.2005.04.017&partnerID=40&md5=36d3fd1417dfecc28b88431720b6a134
dc.description.abstractThe present study aimed to investigate the purgative effects of barakol, the purified extract of Cassia siamea Lam., on the longitudinal smooth muscle contractions of the rat ileum. The extract increased the force of spontaneous muscle contractions in a concentration-dependent manner (EC50 = 0.3 mM). Saxitoxin (0.3 μM) abolished the stimulatory effects of barakol, a result indicating a neural mechanism of action. In addition, atropine (10 μM) but not propanolol (10 μM) or phentolamine (10 μM), partially inhibited barakol-induced smooth muscle contractions suggesting that cholinergic nerves were involved. The motor effects of barakol were further examined in muscle strips treated with catecholamines to suppress spontaneous contractile activity and decrease muscle tone. Norepinephrine or dopamine (10 μM) decreased the amplitude of spontaneous contractions by 72% and 18%, respectively. Pretreatment of the tissues with barakol (1 mM) significantly decreased the inhibitory effect of norepinephrine by 60%, but not that of dopamine. Its ability to potentiate atropine- and saxitoxin-sensitive contractions and inhibit the antimotility actions of norepinephrine suggests that barakol may increase longitudinal smooth muscle contractions by decreasing the inhibitory effect of norepinephrine on excitatory cholinergic motor neurons. Barakol may produce a purgative action in small intestine which may be clinically important in patients with intestinal hypomotility disorders. © 2005 Elsevier Ireland Ltd. All rights reserved.
dc.subjectatropine
dc.subjectbarakol
dc.subjectCassia extract
dc.subjectcatecholamine
dc.subjectdopamine
dc.subjectnoradrenalin
dc.subjectphentolamine
dc.subjectpropranolol
dc.subjectsaxitoxin
dc.subjectunclassified drug
dc.subjectanimal tissue
dc.subjectarticle
dc.subjectcassia siamea
dc.subjectcholinergic nerve
dc.subjectconcentration response
dc.subjectdrug mechanism
dc.subjectileum contraction
dc.subjectintestine innervation
dc.subjectmale
dc.subjectmotoneuron
dc.subjectnonhuman
dc.subjectparasympathetic innervation
dc.subjectrat
dc.subjectSenna
dc.subjectsmooth muscle contraction
dc.subjectsmooth muscle tone
dc.subjectAnimals
dc.subjectBenzopyrans
dc.subjectDopamine
dc.subjectDose-Response Relationship, Drug
dc.subjectIleum
dc.subjectMale
dc.subjectMuscle Contraction
dc.subjectMuscle, Smooth
dc.subjectNorepinephrine
dc.subjectPhenalenes
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectSenna siamea
dc.titleBarakol suppresses norepinephrine-induced inhibition of spontaneous longitudinal smooth muscle contractions in isolated rat small intestine
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of Ethnopharmacology. Vol 101, (2005), p.227-232
dc.identifier.doi10.1016/j.jep.2005.04.017
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.